To validate these results in two independent datasets based on RNA expression,30 we used the KMT2A fusion partner to group KMT2Ar-AML cases into MLLGA, MLLGB and the intermediate MLLT3/MLLT11 group. The gene discussed is MLLT3; the disease is acute myeloid leukemia.